HVAX Technologies , a turnkey pharmaceutical project integrator, is eyeing projects worth ₹682 crore on the back of fresh investments lined up in the pharma space.

The company has an order book of ₹313 crore as of September-end.

The company is a specialist in controlled environments and cleanrooms. It has built viable infrastructure for biotech facilities, hospitals and pharmaceutical facilities, in over 15 countries across the globe.

The company remains optimistic about achieving a breakthrough in the near future. It has also started evaluating opportunities in the semiconductor and solar industries, said the company.

Addressing the growing needs of India’s rapidly expanding hospital services market, HVAX expects to accelerate its entry into these high-growth areas.

HVAX is also in

See Full Page